Scientific Board 2020

Mircea Ciuca

M.D., Global Therapeutic Area Head in Global Clinical Safety and Pharmacovigilance at CSL Behring 

EUPV_Lucia Costanzo

Lucia Costanzo

Responsable person for the organization of EUPV congress

Fernanda Ferrazin

Former Head of Pharmacovigilance Dept. – Italian Medicines Agency – Scientific Board PEC (Pharma Education Center)

Giovanni Furlan

Safety Risk Lead, Director – Pfizer

Valentina Mancini

Director PV, EU QPPV, Shionogi  Europe

Patrizia Rotunno

Pharmacovigilance Consultant, Drug Safety Manager at Pharma D&S

Marco Sardella

Chief Pharmacovigilance Officer , EU QPPV ADIENNE Pharma & Biotech, Chairperson for EUPV Congress

Speakers 2020 in progress

Josè Alberto Ajala Ortiz

PVpharm CEO, EU QPPV,  PV Consultant, LCPPV Services, Spain

Glyn Belcher

CEO of PV Consultancy Ltd

Mario Bertazzoli

M.D., Director, Group Head of Drug Safety and Reference Physician to EU QPPV at Helsinn Healthcare SA 

Raj Bhogal

Raj Bhogal

Sr. Director, R&D Audits & Inspections – Jazz Pharmaceuticals

Laura Boga

QPPV – Dompé Pharmaceutical Spa

Gian Nicola Castiglione

M.D., EU QPPV & Director Global  PV – Chiesi Farmaceutici 

Sara Cazzaniga

Medical Affaire Excellence Head at Janssen-Cilag Italy

Margherita D'Antuono

PharmD, PhD, Corporate  PV Director,  EU QPPV, Italfarmaco 

Barbara De Bernardi

Vice President, EU QPPV Deputy, Pfizer 

Fabio De Gregorio

M.D., Vice President, Head of Drug Safety Europe,
Shionogi Europe

Elisabetta Di Martino

Elisabetta Di Martino

Scientific Director PHARMA D&S

Phillip Eichorn

M.D., Senior Director Worldwide Safety & Regulatory – Pfizer Pharmaceuticals 

Michael Von Forstner

PhD, Senior Director, Pharmacovigilance & Patient Safety – PRA Health Science

Ilaria Grisoni

Sr. Director, EEA QPPV, Jazz Pharmaceutical

Sarah Hall

PhD, HonFPIPA,Managing Director MIPSOL

Paola Kruger

Expert Patient, EUPATI (European Patient’s Academy for Therapeutic Innovation) 

Hervé Le Louët

CEO of the UMC, President of CIOMS, Past President of ISOP, Past Member of PRAC

Calin A. Lungu

M.D., MRQA, BCPM, Eudravigilance and XEVMPD-EMA, CEO-DDCS

Arduino Mangoni

MBBS, MD (Hons), PhD, Professor and Head, Department of Clinical Pharmacology, School of Medicine, Flinders University, Australia

Daniela Marcozzi

Head of R&D QA Company Representative for Competent Health Authorities – Fidia Farmaceutici S.p.A.

EUPV:_Jan Petracek

Jan Petracek

MD. PhD, ISoP Advisory Board at International Society of Pharmacovigilance

Elena Prokofyeva

MD, MPH, PhD, Head of Drug Safety Unit – AFMPS

EUPV_Daniele Sartori

Daniele Sartori

MSc Pharm, Pharmacovigilance Scientist- Uppsala Monitoring Centre

Juergen Schmider

Juergen Schmider

M.D., Ph. D., President Drug and Device Vigilance Consulting LLC – Arisglobal

Francoise Dumas Sillan

M.D., VP Head of Therapeutic area oncology – endocrinology Global patient safety, Ipsen

Doris Irene Stenver

D.M., MPA, Indep. PV Adviser Founder of Unique Advice, former Chief Medical Officer Danish Medicines Agency and former member of PRAC

Alessandra Traversa

Independent Pharmacovigilance Expert

Marco Tuccori

Drug Safety Manager at University Hospital of Pisa

Bert Van Leeuwen

M.D., Deputy-QPPV of Astellas Pharma Europe

Via Dei Pratoni, 16 - 50018 Scandicci (FI)
Tel. (+39) 055 7227007 - 055 7224076 - 055 7224179
E-mail: info@pharmaeducationcenter.it